Xuejun Chen
Xuejun Chen publishes mostly in Hematology, Genetics and Oncology, on topics such as Myeloproliferative Neoplasms: Diagnosis and Treatment, Multiple Myeloma Research and Treatments and Anesthesia and Neurotoxicity Research.
- World rank
- #3,885,051 of 7,710,434 ranked researchers
- Rank in United States
- #1,065,821 of 1,627,098
- Works
- 68
- Citations
- 794
- Citations per work
- 11.7
What does Xuejun Chen research?
Xuejun Chen's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3754.0%
- Health Sciences2536.9%
- Medicine2536.9%
- Life Sciences69.1%
- 1Hematology11% of their works
- 2Genetics10% of their works
- 3Oncology9% of their works
- 4Molecular Biology9% of their works
- 5Public Health, Environmental and Occupational Health4% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Anesthesia and Neurotoxicity Research
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Cancer Immunotherapy and Biomarkers
- Protein Degradation and Inhibitors
Which keywords describe Xuejun Chen's research?
The keywords of their largest research topics: JAK2 Mutation, Myelofibrosis, Prognostic Factors, Diagnosis Criteria, International Myeloma Working Group, Anesthesia, Chronic Lymphocytic Leukemia and Genomic Aberrations.
- BET Bromodomains
- Immune Checkpoint Blockade
- BCR-ABL
- AML
- Genomic Aberrations
- Anesthesia
- Diagnosis Criteria
- Myelofibrosis
- JAK2 Mutation
- Prognostic Factors
- International Myeloma Working Group
- Chronic Lymphocytic Leukemia
- Neurotoxicity
- Acute Myeloid Leukemia
- Imatinib
- PD-1 and PD-L1
- PROTACs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- JAK2 Mutation101 topic
- Myelofibrosis101 topic
- Prognostic Factors92 topics
- Diagnosis Criteria71 topic
- International Myeloma Working Group71 topic
- Anesthesia51 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- Neurotoxicity51 topic
- AML41 topic
- Acute Myeloid Leukemia41 topic
- BCR-ABL41 topic
- Imatinib41 topic
- Immune Checkpoint Blockade41 topic
- PD-1 and PD-L141 topic
- BET Bromodomains31 topic
- PROTACs31 topic
Where does Xuejun Chen work?
Xuejun Chen's main affiliation in the publication record is Incyte (United States), United States.
How many publications and citations does Xuejun Chen have?
OpenAlex counts 68 works and 794 citations for Xuejun Chen, an h-index of 16, ranking #3,885,051 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Xuejun Chen
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Xuejun Chen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.